Key facts, as of
As of November 2, 2026, Danaher Corporation (DHR) trades at $229.61, up 6.6% over the past year. Its 52-week range runs from $160.93 to $242.80; the price is 5.4% below that high. It is 22.4% below its all-time high of $296.06, reached in September 2021. Over the 10 years to the end of October 2026, with dividends reinvested, it returned +251.0%, against +316.3% for the S&P 500 (SPY). It sits 14.2% above its 200-day average of $201.06, and its 50-day average is above the 200-day too: an uptrend on both averages. Its 30-day volatility is 27.9% annualized, which we rate medium risk. It has a trailing P/E of 38.0 and a dividend yield of 0.69%.
Cite: Portfolio Terminal, "Danaher Corporation (DHR) stock analysis", 2026-11-02. https://portfolio-terminal.com/analyse/dhr
Where it trades today
trading 84% of the way up its 52-week range
How the price has moved
How far it is from its record
Danaher Corporation (DHR) is 22.4% below its all-time high of $296.06, reached in September 2021. Over the 10 years to the end of October 2026, with dividends reinvested, it returned +251.0%, against +316.3% for the S&P 500 (SPY).
The read, from its own figures
What its numbers say
- DHR closes above its 50-day average ($219.07), and the 50-day sits above the 200-day ($201.06): on both averages the chart reads as an uptrend.
- At $229.60, DHR is 5.4% below its 1-year high of $242.80, set on January 22, 2026, and 42.7% above its 1-year low of $160.93 (May 15, 2026).
- Over the past month DHR rose 7.3%, from $214.06 to $229.60.
- DHR trades at 38.0x its last twelve months of earnings and 24.6x the next twelve months' estimate, so analysts expect earnings 54.3% higher.
- Its P/E is 5.1% above the 36.2x median of the 3 other diagnostics & research companies we track (TMO, A, WAT).
- DHR's 30-day volatility, 27.9% a year, works out to a typical daily move of about 1.8%.
- Yahoo Finance puts its beta at 0.80: over five years of monthly returns, DHR moved about 0.80% for each 1% move of the S&P 500.
- The last session traded 0.3x DHR's average daily volume of the 30 sessions before it.
What would change the read
- A close under the 50-day average, $219.07 (−4.6% from the last close), would turn the read to a pullback; under the 200-day, $201.06 (−12.4%), the longer rise is in question.
- A close above $242.80 (+5.7%) would be a new 1-year high; below $160.93 (−29.9%), a new 1-year low.
How it is computed
- Prices are Yahoo Finance's daily candles for DHR, the same ones the chart below draws; the P/E, forward P/E and beta are Yahoo Finance quote fields.
- The averages are simple means of the last 50 and 200 closes; the 1-year high and low are the highest high and lowest low of the last 252 sessions; the 30-day volatility is the standard deviation of the past month's daily returns, annualized with the square root of 252.
- Peers are the other companies Yahoo Finance files under diagnostics & research among the assets we track, not a full industry screen; the median counts those with a positive P/E.
- Every sentence here is written by code from those figures, refreshed daily; nobody edits it for DHR by hand. It describes what the price and the multiples have done, not what they will do, and it is not advice.
Sources
- Yahoo Finance quote and daily historyopen →
The candles, the averages' inputs and the quote fields used for DHR. Last refresh: Nov 2, 2026, 7:10 PM UTC.
- How Portfolio Terminal computes its figuresopen →
The methodology page behind the analytics and their refresh cadence.
- Industry classification
Yahoo Finance's industry, as stored in our list of tracked assets: Diagnostics & Research.
What Danaher Corporation does
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design…
Employees
58,000
Industry
Diagnostics & Research
Headquarters
Washington, United States
What analysts expect
DHR carries a strong buy consensus from 21 analysts, with an average price target of $259.90 versus $229.60 today (+13.2%). Targets are estimates and can move quickly after earnings.
Consensus aggregated by Yahoo Finance. Targets are estimates, not forecasts.
How the business is doing
DHR generated $25.61B in trailing revenue (8.3% year over year), with a 16.9% net margin, and $4.75B of free cash flow, against $22.10B of net debt.
The numbers, year by year
| Fiscal year | Revenue | Gross profit | Operating income | Net income | EPS | Free cash flow |
|---|---|---|---|---|---|---|
| 2025 | $24.57B | $14.52B | $4.69B | $3.61B | $5.07 | $5.26B |
| 2024 | $23.88B | $14.21B | $4.86B | $3.90B | $5.33 | $5.30B |
| 2023 | $23.89B | $14.03B | $5.20B | $4.76B | $6.44 | $5.78B |
| 2022 | $26.64B | $16.19B | $7.54B | $7.21B | $9.80 | $7.40B |
When it reports next
Estimates aggregated by Yahoo Finance. Dates move and estimates change until the report lands.
Which ETFs hold it
DHR is in 15 of the 54 ETFs we track. It weighs most in XLV: 2.23% of the fund, holding #12 of 62.
Famous investors who hold it
DHR is in the latest 13F of 5 of the 15 famous investors we follow. Dan Loeb (Third Point) holds the most of it: 2.20% of the portfolio, position #19 of 39, as of Q2 2026.
How its figures compare with those peers
Companies in the same industry
DHR beside the other companies Yahoo Finance files under diagnostics & research among the assets we track (TMO, A, WAT, largest first).
TMOThermo Fisher Scientific$685.90$254.14B
AAgilent Technologies$172.93$48.76B
WATWaters Corporation$452.01$44.38BWhat the chart is saying
In an uptrend, pressing toward $232.59 resistance.
uptrend- Price is 4.8% above its 50-day average and 14.2% above its 200-day.
- The 50-day crossed above the 200-day on 2026-09-14 (a “golden cross”).
- RSI at 55 is neither stretched nor washed out.
- The nearest ceiling is $232.59 (+1.3%), the nearest floor $220.28 (-4.1%).
A description of the chart, not advice. Indicators describe what the price has done; none of them knows what it does next.
Questions people ask about it
How is DHR valued right now?
Danaher Corporation trades at 38.0 times its last twelve months of earnings and 24.6 times the next twelve months' estimate (Yahoo Finance, November 2, 2026). On the chart: in an uptrend, pressing toward $232.59 resistance. Price is 4.8% above its 50-day average and 14.2% above its 200-day.
What is the risk level of DHR?
Based on 30-day volatility of 27.9%, DHR has MEDIUM risk. Its beta of 0.80 means it has swung less than the S&P 500 over the last five years.
Does DHR pay dividends?
Yes, Danaher Corporation has a dividend yield of 0.69%.
How far is DHR from its all-time high?
Danaher Corporation is 22.4% below its all-time high of $296.06, reached in September 2021. Over the 10 years to the end of October 2026, with dividends reinvested, it returned +251.0%, against +316.3% for the S&P 500 (SPY).
Which ETFs hold DHR?
15 of the 54 popular ETFs we track hold Danaher Corporation. The largest weights: XLV (2.23%), VIG (0.61%), VTV (0.53%), RSP (0.22%) and CSPX (0.22%). Measured on each issuer's full holdings file, dated September 30 to October 18, 2026.
How much of VOO is DHR?
0.21%, as of September 30, 2026: DHR is holding #84 of 505 in Vanguard's file for VOO. $1,000 in VOO puts about $2.10 in Danaher Corporation.
Which famous investors own DHR?
Dan Loeb (2.20% of Third Point's 13F), Chase Coleman (0.36% of Tiger Global Management's 13F), Bill Gates (0.21% of Gates Foundation Trust's 13F), Renaissance Technologies (0.20% of Founded by Jim Simons's 13F) and Stanley Druckenmiller (0.18% of Duquesne Family Office's 13F), according to their latest Form 13F filings with the SEC (Q2 2026). A 13F lists US long positions 45 days after the quarter ends, so it can be out of date.
What is the analyst price target for DHR?
The average analyst price target for Danaher Corporation (DHR) is $259.90 based on 21 analyst estimates, about 13.2% above the current price of $229.60. The published range runs from $220.00 to $310.00.
How much revenue does DHR generate?
Danaher Corporation reported $25.61B in trailing twelve-month revenue. Revenue growth is running at 8.3% year over year. Net margin sits at 16.9%. Figures are aggregated from company filings by Yahoo Finance and refresh on an hourly cadence.
Compare DHR with anything
Five years side by side: what $10,000 became, how far each fell, whether they move together.